CLDI
Price
$0.97
Change
+$0.27 (+38.57%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
22.25M
XTLB
Price
$1.55
Change
+$0.32 (+26.02%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
12.36M
Interact to see
Advertisement

CLDI vs XTLB

Header iconCLDI vs XTLB Comparison
Open Charts CLDI vs XTLBBanner chart's image
Calidi Biotherapeutics
Price$0.97
Change+$0.27 (+38.57%)
Volume$117.06K
Capitalization22.25M
XTL Biopharmaceuticals
Price$1.55
Change+$0.32 (+26.02%)
Volume$400
Capitalization12.36M
CLDI vs XTLB Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. XTLB commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Buy and XTLB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (CLDI: $0.70 vs. XTLB: $1.60)
Brand notoriety: CLDI and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 3927% vs. XTLB: 205%
Market capitalization -- CLDI: $22.25M vs. XTLB: $12.36M
CLDI [@Biotechnology] is valued at $22.25M. XTLB’s [@Biotechnology] market capitalization is $12.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, XTLB is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 5 TA indicator(s) are bullish while XTLB’s TA Score has 6 bullish TA indicator(s).

  • CLDI’s TA Score: 5 bullish, 4 bearish.
  • XTLB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, XTLB is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а +199.27% price change this week, while XTLB (@Biotechnology) price change was +33.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

CLDI is expected to report earnings on May 14, 2025.

XTLB is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDI($22.3M) has a higher market cap than XTLB($12.4M). XTLB YTD gains are higher at: -21.019 vs. CLDI (-39.130). XTLB has higher annual earnings (EBITDA): 630K vs. CLDI (-17.73M). CLDI has more cash in the bank: 10.6M vs. XTLB (133K). CLDI (0) and XTLB (0) have equivalent revenues.
CLDIXTLBCLDI / XTLB
Capitalization22.3M12.4M180%
EBITDA-17.73M630K-2,814%
Gain YTD-39.130-21.019186%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.6M133K7,970%
Total Debt4.71MN/A-
FUNDAMENTALS RATINGS
XTLB: Fundamental Ratings
XTLB
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDIXTLB
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
34%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCU0.380.02
+4.66%
Cycurion Inc.
ARKO4.650.11
+2.42%
ARKO Corp
FHI45.900.39
+0.86%
Federated Hermes
SKLZ7.210.03
+0.42%
Skillz
STLD136.080.04
+0.03%
Steel Dynamics

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with DYN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
+108.96%
DYN - CLDI
37%
Loosely correlated
+5.84%
ORYZF - CLDI
37%
Loosely correlated
N/A
RYTM - CLDI
31%
Poorly correlated
+36.63%
LENZ - CLDI
30%
Poorly correlated
+11.03%
IGMS - CLDI
29%
Poorly correlated
+1.50%
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been loosely correlated with SER. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XTLB jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
+30.08%
SER - XTLB
59%
Loosely correlated
+7.95%
CLDI - XTLB
28%
Poorly correlated
+108.96%
UNCY - XTLB
28%
Poorly correlated
+8.25%
BCLI - XTLB
27%
Poorly correlated
-5.34%
ANRO - XTLB
27%
Poorly correlated
+3.20%
More